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Abstract
Genetic strategies that reduce or block pathogen transmission by mosquitoes have been proposed as a means of
augmenting current control measures to reduce the growing burden of vector-borne diseases. The endosymbiotic
bacterium Wolbachia has long been promoted as a potential vehicle for introducing disease-resistance genes into
mosquitoes, thereby making them refractory to the human pathogens they transmit. Given the large overlap in tissue
distribution and intracellular localization between Wolbachia and dengue virus in mosquitoes, we conducted experiments
to characterize their interactions. Our results show that Wolbachia inhibits viral replication and dissemination in the main
dengue vector, Aedes aegypti. Moreover, the virus transmission potential of Wolbachia-infected Ae. aegypti was significantly
diminished when compared to wild-type mosquitoes that did not harbor Wolbachia. At 14 days post-infection, Wolbachia
completely blocked dengue transmission in at least 37.5% of Ae. aegypti mosquitoes. We also observed that this Wolbachia-
mediated viral interference was associated with an elevated basal immunity and increased longevity in the mosquitoes.
These results underscore the potential usefulness of Wolbachia-based control strategies for population replacement.
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Introduction
Dengue fever and its associated condition, the highly lethal
dengue hemorrhagic fever, are emerging globally as the most
important arboviral diseases currently threatening human popu-
lations. Approximately 2.5 billion people are at risk of contracting
dengue-associated disease, with an estimated 50–100 million cases
occurring each year [1]. Dengue virus (DENV) is transmitted to
humans by aedine mosquitoes, primarily Aedes aegypti and, to a
lesser extent, Aedes albopictus. At present, no treatment or vaccine is
available for dengue fever; thus, vector control is currently the
primary intervention tool. One such method is population
replacement, in which natural Ae. aegypti populations would be
replaced with modified populations that are unable to transmit
DENV. Recently, significant progress has been made in producing
Ae. aegypti strains that are refractory to DENV [2,3] and in
exploring transgene drivers for population replacement [4,5].
One of the most promising transgene drivers is a maternally
transmitted Gram-negative endosymbiotic bacterium, Wolbachia.
Significantly, Wolbachia is able to spread rapidly within an
uninfected Ae. aegypti laboratory population after the population
has been seeded with infected females [6]. Wolbachia induces a
reproductive abnormality known as cytoplasmic incompatibility
(CI), which results in early embryo death when a Wolbachia-
infected male has mated with a female that is uninfected or
harboring a different Wolbachia type. Since uninfected males can
successfully mate with infected females, Wolbachia and any gene it
carries can spread quickly in a population.
Two control approaches using Wolbachia-based population
replacement have been proposed: One potential approach
involves linking a transgene to Wolbachia. The mosquito’s vectorial
capacity is reduced as the transgene is carried by Wolbachia into the
target population. The second approach utilizes the ability of
Wolbachia itself to modify both the sexual reproduction and
vectorial capacity of the host. For example, after mosquitoes are
fed an infectious blood meal, a period of 7–14 days (depending on
environmental and intrinsic factors) is required before the
mosquitoes are able to transmit DENV to a new host [7,8]. One
strain of Wolbachia, called popcorn, has been shown to reduce the
longevity of mosquitoes, causing the insects to die before they can
transmit viruses [9,10]. Wolbachia, introduced into wild vector
populations, will inevitably encounter DENV, given large overlap
in tissue distribution and intracellular localization of these two
microorganism [8,11]. However, at present it is still unclear how
Wolbachia and DENV interact in the mosquito.
Recent studies in Drosophila have shown that Wolbachia can
confer resistance to diverse RNA viruses and protect flies from
virus-induced mortality [12,13]. Two groups have independently
reported that Wolbachia significantly reduces the infection level of
the Drosophila C virus, a member of the Dicistroviridae, in different
lines of D. melanogaster. When compared to flies cured of Wolbachia
infection, those with an active Wolbachia infection showed a
significantly delayed mortality induced by Drosophila C virus
infection. A similar antiviral effect was also observed in Wolbachia-
infected flies challenged with cricket paralysis virus (Dicistroviridae),
Nora virus (a new picorna-like virus family) and flock house virus
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stranded positive-sense RNA viruses, these findings strongly
support the existence of an overarching mechanism that is also
applicable to Wolbachia-DENV interactions in their mosquito
hosts.
Although Ae. aegypti is not naturally infected by Wolbachia,
infection has been achieved by transfection with wAlbB, an
infection type of Wolbachia from Ae. albopictus, by means of
embryonic microinjection [6]. wAlbB is able to induce a complete
CI in Ae. aegypti, and this phenotype can be reversed by tetracycline
treatment. Moreover, it has a 100% maternal transmission rate,
with no fitness costs observed [6]. Since it was introduced, this
infection has been stably maintained in Ae. aegypti for about 6 years
in the laboratory.
Our previous studies have shown that the mosquito’s endoge-
nous bacterial flora boost the basal level of immunity in the
mosquito and that their removal leads to an increase in the level of
dengue infection [14]. In the Drosophila S2 cell line, we also found
that Wolbachia activates immune signaling pathways and induces
the expression of antimicrobial peptide genes [15]. In Ae. egypti,w e
have further demonstrated that the anti-bacterial defense respons-
es can control dengue infection [14]. Here, we have asked whether
Wolbachia, a component of the mosquito’s microbial flora, can
suppress DENV in Ae. aegypti. We found that Wolbachia can indeed
inhibit DENV infection in Ae. Aegypt, and this inhibition was
associated with an elevated immune response and an increase in
the mosquito’s longevity.
Results
Wolbachia-induced suppression of DENV replication in
the mosquito midgut
To characterize the effect of Wolbachia on DENV infection in Ae.
aegypti, we compared DENV dynamics within the mosquito
between the original wild-type Waco strain (Wolbachia-free) and
the Waco-derived WB1 strain (Wolbachia-transfected). Mosquitoes
were fed sheep blood containing the New Guinea C strain of
DENV serotype 2 (DENV-2), with viral titers of 2.0610
7 PFU/ml.
Using an indirect fluorescent antibody assay (IFA) performed on
head squashes at 14 days after the infectious meal, we had
previously confirmed that this virus titer resulted in a .90%
infection rate in experimentally infected Waco females.
The number of copies of DENV-2 genomic RNA was
monitored in mosquito midguts by quantitative reverse transcrip-
tase PCR (qRT-PCR) at 3, 6, 9, 12, 15 and 18 days post-infection.
Five biological replicates were used for each time point. The
number of copies of DENV-2 RNA in the WB1 strain was
significantly lower than that in Waco strain at all five time points,
with the exception of Day 9 (Mann-Whitney U test, P,0.05)
(Figure 1). On Days 3 and 6, DENV was detectable in only one of
ten WB1 samples, whereas all the Waco samples were positive for
dengue infection. On Day 9, the median viral titer in the WB1
strain reached 9.1610
3 genome copies per midgut, whereas the
median titer in the Waco strain was 2.4610
6 genome copies per
midgut; however, this difference was not statistically significant.
RNA copy numbers remained at a high level in the midguts of
Waco strain mosquitoes from Day 9 to 18.
The strongest Wolbachia-mediated virus inhibition was observed
on Day 12, when the amount of DENV-2 in the midguts of the
WB1 strain mosquitoes was 5.6610
4 times lower than that in the
midguts of the Waco strain. The dengue infection level in the WB1
midgut was maintained at 1.9610
4 and 3.1610
4 times lower than
that in Waco midguts on Days 15 and 18, respectively. A low level
of DENV-2 infection, ranging from 23.0 to 31.5 copies per
midgut, was maintained in the midguts of the WB1 line from Day
12 to 18 (Figure 1).
Wolbachia-induced suppression of DENV dissemination
to the thorax and head of the mosquito
We also compared the dissemination of DENV-2 within the
WB1 and Waco strains of Ae. aegypti by measuring the number of
copies of the dengue genome in the mosquito thorax. From Day 3
to Day 9, we saw no significant difference in the level and
prevalence of dengue infection between the WB1 and Waco
strains. A very low level of infection was detected in one of five
replicates in both strains on Day 6. On Day 9, all five Waco
replicates and four of the five WB1 replicates were positive for
dengue infection. Whereas DENV-2 accumulated in the thorax
of the Waco strain mosquitoes from Day 12 to 18, a strong
Wolbachia-mediated inhibition effect was observed in the WB1
mosquitoes. On Day 12, the amount of DENV-2 in the thoraces
of the WB1 mosquitoes was 2.6610
5 times lower than in the
Waco strain (Mann-Whitney U test, P,0.05) (Figure 2A). On
Days 15 and 18, three of five WB1 replicates had no detectable
dengue infection, whereas all the Waco thoraces were heavily
infected by DENV.
Similar results were obtained when we used IFA to assay female
heads. Only 38.9% of the mosquitoes were positive for the DENV-
2 E protein in the heads of WB1 mosquitoes by Day 14, as
compared to 94.4% of the Waco mosquitoes (Fisher’s exact test,
p,0.05). By Day 21, 91.7% of the Waco strain mosquitoes were
positive for DENV in the head squash assay, whereas only 5.6% of
the WB1 strain mosquitoes were positive (Fisher’s exact test,
p,0.05) (Figure 2B). These results indicate that inhibition of
DENV dissemination in the mosquito increases with time.
Experiments were also conducted to examine whether a similar
Wolbachia-mediated inhibition of DENV could occur in Ae.
albopictus. After both Wolbachia-infected and uninfected Ae. albopictus
were fed on the same infectious blood, 100% of the mosquitoes
were positive in the head squash assay in both groups (Figure 2B).
Thus, Wolbachia-mediated inhibition of DENV was not observed
in Ae. albopictus, at least not when this particular viral titer of the
infectious blood was used to infect the mosquitoes.
Author Summary
Dengue fever and its associated condition, dengue hemor-
rhagic fever, are emerging globally as the most important
arboviral diseasescurrentlythreateninghumanpopulations.
Dengue virus is transmitted to humans by aedine mosqui-
toes, primarily Aedes aegypti and, to a lesser extent, Aedes
albopictus. No treatment or vaccine is currently available for
dengue fever; thus, vector control remains the primary
intervention tool. One novel control strategy for reducing or
blocking dengue transmission by mosquitoes involves the
endosymbiotic bacterium Wolbachia, which has long been
promoted as a potential vehicle forintroducinganti-dengue
genes into mosquitoes. Here, we have characterized the
interaction of Wolbachia with dengue viruses in Ae. aegypti.
Wolbachia alone was able to inhibit viral replication,
dissemination and transmission in these mosquitoes. In
addition, this Wolbachia-mediated viral interference was
associated with an elevation of basal immunity and increase
in longevity in the mosquitoes. Our study provides novel
insights into the usefulness of Wolbachia for blocking
dengue transmission by mosquitoes.
Wolbachia-Dengue Interactions
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potential of Ae. aegypti
To determine whether mosquitoes’ potential to transmit
DENV-2 was inhibited by Wolbachia, we compared the levels of
virus particles released during feeding from the proboscis of WB1
and Waco strain mosquitoes. At 14 days post-infection, the
mosquitoes were allowed to feed on an artificial feeding solution
for 90 min, and the viral titers in the solution were then measured
by plaque assay. The median titer of viruses released from the
mosquito proboscis was 12 times higher in the Waco strain
(5.5610
2 pfu/ml) than in the WB1 strain (45 pfu/ml) (Mann-
Whitney U test, P,0.05) (Figure 3). The virus infection rate of the
feeding solution from the Waco strain was also significantly higher
than that from the WB1 strain. Of the eight groups of pooled
feeding solution from WB1 mosquitoes, three had no titer of virus
at all, and one had a titer of 10 pfu/ml. Because each feeding
group consisted of eight female mosquitoes, this result indicates
that Wolbachia can completely block dengue transmission potential
in at least 37.5% (24 of 64) of WB1 mosquitoes. In contrast,
positive titers were detected in all the eight groups of pooled
feeding solution from the Waco strain, and three groups had viral
titers of 1.1610
4 to 7.6610
4 pfu/ml. These observations were
consistent with the results from trituration of the whole bodies
from each mosquito group: The median titer of the five Waco
groups was 1.6610
4 pfu/ml virus, as compared to 2.5610
3 pfu/ml
virus for the eight WB1 groups. No virus was detected in one of
eight WB1 whole-body groups (Figure 3). These results suggest
that the DENV-2 transmission potential had been greatly reduced
by Wolbachia in Ae. aegypti.
In order to allow us to correlate the data between different assays,
we compared the dengue infection levels in the Waco and WB1
strains at 7 days post-infection, in parallel with the results of the
qRT-PCR and plaque assays. Although both the assays showed a
significant reduction in the viral infection in the midguts and whole
bodies, qRT-PCR showed a higher -fold reduction than the plaque
assay in both tissues (Table S1). In particular, the virus infection in
whole bodies and midguts were reduced by 2.4610
4- and 100-fold
according to the qRT-PCR results, but only by 139.4- and 10.6-
fold, respectively, when measured by plaque assay. Moreover,
comparison of the inhibition in midguts and whole bodies also
showed a difference, with whole bodies exhibiting stronger
inhibition than midguts at 7 days post-infection (Table S1).
Wolbachia tissue distribution, density and infection
frequency in the WB1 strain
Wolbachia-mediated viral inhibition might be related to the tissue
distribution, density and infection frequency of Wolbachia in WB1
mosquitoes. In our analysis of these aspects of Wolbachia infection,
we focused on midguts and salivary glands, two important tissues
targeted by DENV. The number of copies of Wolbachia genomic
RNA in the two tissues was measured by quantitative PCR and
compared to that in the ovaries. Wolbachia was present in both
midguts and salivary glands at a 3- to 5-fold lower density than in
ovaries: Specifically, there were 16.5 and 27.2 copies of the
Wolbachia genome (normalized by the ribosomal protein S6
[RPS6] copy number) in the midguts and salivary glands,
respectively, as compared to 91.5 copies in the ovaries (Figure 4).
In order to confirm that each individual WB1 mosquito was
carrying the Wolbachia bacterium, we randomly selected 15 females
from the current WB1 population cage and tested their infection
status by PCR. As had been observed 6 years ago [6], all of the 15
were positive for Wolbachia.
Up-regulation of Toll pathway genes in Ae. aegypti by
Wolbachia
The results of our previous studies have suggested that microbial
flora in the mosquito might mediate the anti-dengue response by
Figure 1. Inhibition of dengue infection in the mosquito midgut by Wolbachia. At 3, 6, 9, 12, 15 and 18 days after a blood meal containing
DENV-2, mosquito midguts were collected, and the number of genome copies of the DENV genome was determined by qRT-PCR using primers for
the NS5 gene; the results were normalized to the Ae. aegypti ribosomal protein S7 (RPS6). Lines indicate the median of the five biological replicates.
Significance was determined using a Mann-Whitney U test (P,0.05).
doi:10.1371/journal.ppat.1000833.g001
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investigated the possibility that Wolbachia can elevate basal
immunity in Ae. aegypti. By comparing the expression of selected
immune genes in 4- or 5-day-old non-blood-fed females of the
Waco and WB1 strains, we found that a number of immune genes
were up-regulated by Wolbachia (Figure 5). Specifically, Wolbachia
Figure 2. Inhibition of dengue dissemination to the mosquito thorax and head by Wolbachia.A . At 3, 6, 9, 12, 15 and18 days after a blood
meal containing DENV-2, mosquito thoraces were collected, and genome copies of dengue virus were measured by qRT-PCR using primers for the NS5
gene and normalized with Ae. aegypti RPS6. Lines indicate the median of the five biological replicates. Significance was determined using a Mann-
Whitney U test (P,0.05). B. The DENV-2 infection rate was determined by an indirect fluorescent antibody assay performed on head squashes of
individual Waco and WB1 females of Ae. aegypti at 14 and 21 days (n=36) or of Houston and HT1 females of Ae. albopictus at 14 days post-infection
(n=30).DatashownaremeansofthreereplicatesforWacoandWB1andtworeplicatesforHoustonandHT1,andthebarsindicatestandarderror.There
was a significant difference in the infection rate between the Waco and WB1 strains at both 14 and 21 days post-infection (Fisher’s exact test, p,0.05).
doi:10.1371/journal.ppat.1000833.g002
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increase in cecropin expression. Up-regulation was also observed
for other Toll pathway genes, including Rel1, Spz1A and
GNBPB1. These results indicate Wolbachia can activate the Toll
pathway and boost basal level immunity in Ae. aegypti. Considering
that the mosquito Toll pathway can control dengue infection in
mosquitoes, this effect might represent a potential mechanism
underlying the suppression of dengue infection by Wolbachia.
Figure 3. In vitro assay of DENV-2 transmission by Waco and WB1 mosquitoes at 14 days post-infection. After the wings and legs had
been removed, the proboscis of each mosquito was inserted into a feeding solution for 90 min. Solutions from eight mosquitoes were pooled as one
group and analyzed for infectious DENV-2 by plaque assays. The viral titers of each group of mosquitoes after feeding on the solutions were also
analyzed in parallel. Lines indicate the log of the median values from five or eight biological replicates. Viral titers were significantly higher in the
Waco strain than the WB1 strain for both the feeding solution and whole body (Mann-Whitney U test, P,0.05).
doi:10.1371/journal.ppat.1000833.g003
Figure 4. Wolbachia density in the ovaries, midguts and salivary glands of WB1 mosquitoes. Total RNA was extracted from one ovary or
midgut or a pool of three salivary glands using the RNAeasy kit. q-PCR was conducted using primers targeting the wAlbB-wsp gene. The Wolbachia
genome copy number was normalized with Ae. aegypti RPS6. Two recombinant plasmids containing the targeted fragments were used to generate
separate standard curves for wAlbB-wsp and RPS6. Ten biological replicates were used for each tissue. Error bars represent the standard error;
different letters are significantly different (ANOVA, P,0.05).
doi:10.1371/journal.ppat.1000833.g004
Wolbachia-Dengue Interactions
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infected Ae. aegypti
To determine whether suppression of DENV-2 infection by
Wolbachia provides any benefit to the mosquito, we compared the
relative survival of the Waco and WB1 strains after infection with
DENV-2. WB1 females lived significantly longer than Waco
females (logrank test, P,0.05) (Figure 6A). This difference was
manifested at a late stage, with all of the Waco females having died
by 26 days post-infection, but 10% of the WB1 females living for
up to 12 additional days. This result produced a ‘‘long tail’’ effect
in the survivorship distribution. To determine whether this
increase in WB1 survival was specifically associated with DENV-
2 infection, we fed Waco and WB1 mosquitoes with blood lacking
DENV. Under these conditions, we observed no difference in
survival between the two strains (Figure 6B). These results
indicated that Wolbachia can slightly increase the longevity of
WB1 only when the mosquitoes are infected with DENV.
Discussion
Ae. aegypti is not naturally infected by Wolbachia, but a transfected
line WB1 was previously successfully developed in the laboratory.
This WB1 line was able to invade the wild-type laboratory
population; population replacement can occur in seven genera-
tions after the initial release [6]. Although Wolbachia is widely used
as a driver to spread disease-resistant genes into the mosquito, the
impact of Wolbachia itself on pathogens has not been well
understood. Given the large overlap in the tissue distribution
and intracellular localization of Wolbachia and DENV in
mosquitoes, we conducted experiments to characterize the
interactions between Wolbachia and DENV. Our results show that
Wolbachia inhibits viral replication, dissemination and transmission
in mosquitoes. This inhibitory effect was associated with an
elevated level of basal immunity in the mosquitoes.
We found that the inhibition of DENV infection in Wolbachia-
infected WB1 mosquitoes occurred in a variety of tissues. This
observation might reflect the broad tissue distribution of wAlbB in
the WB1 strain, especially in those tissues in which DENV
replicates and resides within the mosquito. DENV enters the
mosquito midgut epithelial cells following an infectious bloodmeal,
with the infection reaching a peak in the midgut from 7 to 10 days
post-infection, in the salivary glands from 10 to 17 days post-
infection, and in the head after 14 days post-infection [8]. We
confirmed the presence of Wolbachia in the midguts and salivary
glands as well as the ovaries of WB1 mosquitoes. Although the
amount of Wolbachia in ovaries was three to five times higher than
that in the midguts and salivary glands, a significant level of
Wolbachia was also present in those two tissues. This distribution
pattern of wAlbB was consistent with what was observed in the
original host, Ae. albopictus, in which Wolbachia is widely distributed
throughout the host tissues, both reproductive (e.g., ovaries and
testes) and non-reproductive (e.g., hemolymph, midgut, muscle,
wing and head) [11].
In our study, the viral inhibitory effects mediated by Wolbachia
were consistently observed in different assays, at different time
points and in different tissues. At 14 days post-infection, all the
Waco strain feeding solutions contained DENV, but at least 37.5%
of the WB1 feeding solutions had no DENV, as determined by
plaque assay. Similarly, the DENV genome could not be detected
by qRT-PCR in 40% (6/15) of the WB1 midguts or 60% (9/15) of
the WB1 thoraces at 15 days post-infection; 61.1% of the WB1
mosquito heads were also negative for the DENV-2 E protein, as
detected by IFA at 14 days post-infection. However, it appeared
that Wolbachia differentially affects the replication of DENV and
Figure 5. Expression of selected immune genes induced by Wolbachia in Waco and WB1 mosquitoes. qRT-PCR was performed using
whole bodies of 4- or 5-day-old non-blood-fed females, with three biological replicates for each gene. Gene expression data were normalized with
RPS7. The primer sequences have been reported previously [14]. The bars indicate standard error.
doi:10.1371/journal.ppat.1000833.g005
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both the midguts and whole bodies at 7 days post-infection was
higher when measured by qRT-PCR than when measured by
plaque assay.
Our results also indicated that the level of inhibition was
different in different tissues and at different time points. This
variation might be related to the dynamics of DENV and the
distribution of Wolbachia in mosquitoes. For example, Wolbachia
might mediate a stronger viral inhibition in a tissue that contains a
higher amount of Wolbachia but a low level of DENV than in
another tissue that contains a low amount of Wolbachia but a high
level of DENV. Although a significant reduction in dengue
infection was observed on Days 3, 6, 12 and 15 in the midguts of
WB1 mosquitoes, the number of viral genome copies on Days 3 to
9 was not significantly different in the thoraces of WB1 mosquitoes
than in those of Waco mosquitoes. In contrast, only a trend toward
a reduction was observed, perhaps because most of the DENV had
not yet escaped from the midgut during this period. The very low
number of virus particles present there made it difficult to
distinguish between signal and noise in the assay.
Inhibition of DENV might be caused by the activation of
certain host defense responses as a result of Wolbachia infection.
Virus-inhibitory effects have been observed in human infected
with a close relative of Wolbachia, Orientia tsutsugamushi; these effects
appear to be caused by binding to the virus of antibodies against
bacteria [16]. In arthropods, innate immunity plays an important
role in limiting pathogen infection. Such immune responses are
largely regulated by two main pathways, the Toll and Imd
pathways [17,18]. In Drosophila, the Toll pathway is mainly
involved in defense against fungi and Gram-positive bacteria,
while the Imd pathway affects resistance to Gram-negative
bacteria. In response to either the Drosophila X virus (a member
of the Birnaviridae)o rE. coli infection, D. melanogaster induces the
same antimicrobial peptide genes. This commonality suggests that
these two diverse classes of pathogen can activate the same
immune response pathway in the insect host [19]. More
importantly, we have recently found that activation of the
mosquito Toll pathway can suppress DENV infection [14]. A
recent genome-wide analysis of the Wolbachia-host interaction has
revealed that Wolbachia infection has an impact on a broad range
of physiological systems in the host, including innate immunity
[15].In the present study, we also observed an elevated mosquito
immune response in the WB1 strain. Thus, the observed inhibition
of dengue infection in the WB1 strain may be partially explained
by a Wolbachia-induced up-regulation of Toll pathway genes.
Alternatively, Wolbachia-mediated viral interference could also
be the result of a direct competition between DENV and Wolbachia
for the same resources, or of an indirect perturbation by Wolbachia
of the cellular environment required by DENV. As a parasite,
DENV depends on the metabolic network of the host cell to
provide the energy and macromolecular subunits necessary for its
replication. By producing metabolic alterations in its host,
Wolbachia may interfere with dengue replication.
It is unlikely that the inhibitory effects on DENV that we
observed in the WB1 mosquitoes were caused by differences in
genetic background between the WB1 and Waco strains. After the
WB1 strain was initially produced from the Waco strain by
embryo microinjection, 50 virgin WB1 females were out-crossed
with 50 Waco males for six generations to homogenize their
genetic background [6]. Since then, the population cages housing
the Waco and WB1 strains have been maintained in the
laboratory under identical environmental conditions.
While this manuscript was in review, an independent report
with similar findings to ours was published: In agreement with our
data, another type of Wolbachia, popcorn, was found to inhibit the
ability of a range of pathogens, including DENV, Chikungunya,
and Plasmodium, to infect Ae. aegypti [20]. This result indicates that
Wolbachia may induce a general killing mechanism in the host or
influence common host factors or networks that are required for a
variety of parasites. It appears that such an effect occurs locally but
not systematically, because DENV can be present in cells of
Wolbachia-infected mosquitoes that lack Wolbachia, and the strength
of the effect depends on the on-site density and the type of
Wolbachia. In addition, in neither this published study nor our
current study was a similar interference effect observed in Ae.
albopictus or Ae. fluviatillis, in which Wolbachia infection occurs
naturally. This apparent selectivity suggests that the observed
interference may require a specific Wolbachia/host combination, or
it may be associated with the recent establishment of Wolbachia in
the host.
Our results suggest the DENV-2 transmission potential in Ae.
aegypti can be strongly inhibited by concurrent infection with
Wolbachia. At 14 days post-infection, Wolbachia in Ae. aegypti could
completely block dengue transmission in at least 37.5% of the
mosquitoes. This inhibitory effect appeared to become stronger over
time. While more than 90% of the female heads were infected in the
Figure 6. Longevity of Waco and WB1 mosquitoes fed with blood mixed with or without DENV. After mosquitoes were fed a blood meal,
either containing DENV (A) or not (B), they were maintained in an incubator at 27uC and 85% humidity. The data shown are means of three replicates
(25 for each), and the bars indicate standard error. Results from two independently reared cohorts are shown (cohort 1 [A]; cohort 2 [B]). The survival
curves were significantly different between the Waco and WB1 mosquitoes fed with dengue-infected blood (logrank test, p,0.0001).
doi:10.1371/journal.ppat.1000833.g006
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dropped from 38.9% to 5.6% between those two days in the case of
the WB1 strain. Wolbachia-induced inhibition of DENV infection
provides us with a bonus for using this endosymbiont to block dengue
transmission in the mosquito. The anti-dengue effect of this
endosymbiont is not solely dependent on the effector transgenes
carried by Wolbachia. Therefore, the main requirement for the
effector transgenes is merely to eliminate any dengue viruses that
survive the Wolbachia-induced suppression. This added advantage
might enhance the efficiency of an anti-dengue effector, because a
lesser dose of effector would be necessary when it is expressed by and
delivered from Wolbachia than if it were to function alone. The anti-
dengue effect of Wolbachia can also reduce concerns over losing the
link between antipathogen and the transgene driver, because
Wolbachia alone can confer resistance to DENV in mosquitoes. Also,
Wolbachia m a yb ea b l et ob eu s e dd i r e c t l yt ob l o c k i n gd e n g u e
transmission without linkage to an anti-dengue gene. This strategy
will, however, require a better understanding of the mechanism
underlying the dengue inhibition effect conferred by Wolbachia.B y
improving the efficiency of this inhibition mechanism, a complete
blockade of dengue transmission could potentially be achieved.
Finally, although DENV was still present in the proboscis of some
WB1 mosquitoes in our study, the titer was 12 times lower than in the
Waco strain. It will be interesting to know whether this level is below
the threshold viral titer that is required to cause infection in humans.
As has been reported in Drosophila [12,13], we observed that
wAlbB could increase the survival rate of the dengue-infected
mosquitoes. Such an increase in survival was not observed when
WB1 were fed uninfected blood. However, in another study, when
Ae. albopictus were fed with blood without DENV, Wolbachia (a
superinfection of wAlbA and wAlbB, referred as wAlbA&B) was
reported to provide a fitness advantage, including an increase in
the mosquitoes’ longevity [21]. This difference in the observed
results might reflect differences in experimental design, infection
status, or mosquito species. Thus far, Wolbachia has been reported
to affect the life span of its mosquito hosts in two different
directions, with the longevity reduced or increased by wMelPop or
wAlbA&B, respectively [9,10,21]. Although the underlying
mechanism is still unclear, it is possible that Wolbachia interacts
with certain biological pathways, such as the insulin signaling
pathway [22], which can influence the host’s life span.
It is still unknown whether this slight increase in survival that we
observed for the infected mosquitoes could have a negative effect
on disease control. To test this possibility, it will be necessary to
determine whether this small fraction of older WB1 mosquitoes
has cleared the viral infection, and whether these mosquitoes still
have the ability to feed on their hosts. Moreover, the longevity of
mosquitoes in the field, where the majority live fewer than 30 days,
is quite different from that of mosquitoes reared under laboratory
conditions. Future studies are needed to assess the overall impact
on dengue transmission of this wAlbB-induced resistance to
dengue infection and increase in life span.
In summary, we have demonstrated an inhibitory effect of
Wolbachia on DENV in Ae. aegypti. This inhibition, which was
found to occur in the midgut, thorax and head, further reduced
the DENV transmission potential of the mosquitoes. We have also
provided evidence that the inhibitory effect may be related to an
elevated basal immunity produced by the Wolbachia. Our results
provide support for future experiments to elucidate the mechanism
underlying the inhibition of dengue infection by Wolbachia and to
dissect the three-way interactions among DENV, Wolbachia and
the mosquito. From an application standpoint, we have demon-
strated that Wolbachia can be used not only as a transgene driver
but also as an effector to suppress dengue infection in the mosquito
Ae. aegypti. When compared to other potential driver systems, the
effector function of Wolbachia offers an additional advantage and
facilitates its implementation as a means of blocking dengue
transmission by mosquitoes.
Materials and Methods
Mosquito rearing and cell culture maintenance
All the mosquito strains used in these experiments, including the
wild-type Waco strain and the transfected line WB1 of Ae. aegypti,
the wild-type Houston strain and tetracycline-treated HT1 strain
of Ae. albopictus, were maintained on sugar solution at 27uC and
85% humidity with a 12-hr light/dark cycle according to standard
rearing procedures. The Ae. albopictus cell line C6/36 was grown in
minimal essential medium (MEM) with 10% heat-inactivated FBS,
1% L-glutamine, and 1% non-essential amino acids at 32uC and
5% CO2.
DENV-2 infections
The New Guinea C strain of DENV-2 was propagated in C6/
36 cells according to standard conditions [23]: In brief, 0.5-ml
aliquots of virus stock were used to infect 75-cm
2 flasks of C6/36
cells, at 80% confluence, with a multiplicity of infection (MOI) of
3.5 virus particles/cell. Infected cells were incubated for 10 days,
and the medium was changed on Day 5. Cells were harvested with
a cell scraper and lysed by repeated freezing and thawing in dry ice
and a 37uC water bath. The resulting virus suspension was mixed
1:1 with commercial human blood. A flask with uninfected C6/36
cells was maintained under similar conditions and used to create
the noninfectious blood meal that served as our control. The blood
meal was maintained at 37uC for 30 min prior to use for feeding
7-day-old mosquitoes (http://www.jove.com/index/Details.stp?
ID=220).
Mosquito dissections
Mosquitoes at 3, 6, 9, 12 and 15 days post-infection were
dissected to collect the midguts and thorax in RNALater, with
three individual mosquitoes in a single replicate. Five replicate
biological assays were performed. Total RNA was extracted using
the RNeasy kit (QIAGEN). To measure the virus titers in
mosquito bodies, at 14 days after a blood meal, mosquitoes were
briefly washed in 70% ethanol, then rinsed in sterile distilled
water. The midgut and thorax were dissected in sterile PBS and
transferred separately to microcentrifuge tubes containing 150 ml
of MEM, then homogenized with a Kontes pellet pestle motor in a
sterile environment.
Real-time qPCR assays
To measure the number of viral genome copies, total virus RNA
was extracted using the RNeasy kit (QIAGEN) and reverse-
transcribed using Superscript III (Invitrogen, Carlsbad, California,
USA) with random hexamers. qRT-PCR was conducted using
primers targeting the dengue NS5 gene and the host RPS6 [24].
The dengue genome copy number was normalized using the RPS6
results. Two recombinant plasmids containing the targeted
fragments were diluted from 10
1 to 10
8 copies/reaction and used
to generate separate standard curves for NS5 and RPS6. Real-
time quantitation was performed using the QuantiTect SYBR
Green PCR Kit (Qiagen) and ABI Detection System ABI Prism
7000 (Applied Biosystems, Foster City, California, USA). Three
independent biological replicates were assayed, and all PCR
reactions were performed in triplicate. To determine the number
of copies of the Wolbachia genome and assess the expression of
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previously described [14,25].
Plaque assays for DENV-2 virus titration
Virus titers in the tissue homogenates were measured as pre-
viously reported (http://www.jove.com/index/Details.stp?ID=
220): The virus-containing homogenates were serially diluted
and inoculated into C6/36 cells in 24-well plates. After incubation
for 5 days at 32uC and 5% CO2, the plates were assayed for plaque
formation by peroxidase immunostaining, using mouse hyperim-
mune ascitic fluid (MHIAF, specific for DENV-2) and a goat anti-
mouse HRP conjugate as the primary and secondary antibodies,
respectively.
Indirect immunofluorescence assay (IFA)
On Days 14 and 21 after infection, the viral antigen in the heads
of mosquitoes was detected by using an indirect IFA. Mosquito
heads were cut off from the thorax with a razor blade, transferred
to a pre-cleaned glass microscope slide, and then squashed under a
cover slip. After being air-dried for 10 min at room temperature,
the slides were fixed in cold acetone (220uC) for 10 min and then
dried. A mouse anti-dengue complex monoclonal antibody
(Millipore) and a fluorescein-conjugated affinity-purified second-
ary antibody (Millipore) were used in all head squash assays.
Specimens were examined with a Zeiss (Germany) fluorescence
microscope. For the samples that yielded ambiguous results in the
IFA assay, RT-PCR was conducted in parallel to confirm the
infection status.
Longevity assay
Adult female 1-week-old mosquitoes were fed with either blood
alone or with blood mixed with DENV-2, as described in the
section on DENV-2 infections. After 30 min of feeding, the
engorged females were sorted on the Carbon Dioxide Staging,
transferred to cardboard containers and then incubated at 27uC
with 80% humidity while being fed a 10% sucrose solution. All
containers were checked for deaths daily, and the surviving
mosquitoes were transferred to a new clean container every week
until all the mosquitoes died. The parameter used to measure
lifespan was the mean of the survival percentages for three
biological replicates of 25 mosquitoes each.
Transmission assay
Mosquitoes that had been infected with DENV-2 as described
above were maintained for 14 or 21 days for forced salivation
assays. The assays were conducted as previously reported [2,26]:
In brief, mosquitoes were deprived of food for 24 h prior to forced
salivation. The legs and wings of each mosquito were cut away,
and the proboscis was inserted into 25 ml of feeding solution (50%
FBS/164 mM NaCl/100 mM NaHCO3/0.2 mM ATP/<50 mg
sucrose/phenol red, pH 7.0) [2] in a 0.2-ml PCR tube. After
90 min, the mosquitoes were removed, and the feeding solutions
from eight mosquitoes (one group) were combined and sterilized
by Millex-GV filter for plaque assays. Whole bodies of eight
mosquitoes from the same group were homogenized in 350 ml
MEM. After filtration, the supernatant was used for plaque assay.
Eight biological replicates were used for each treatment.
Accession numbers
The Entrez Gene IDs for the genes and proteins mentioned in
the text are 5565922 (Cactus), 5569526 (REL1A), 5578608
(Caspar), 5569427 (REL2), 5579094 (DEF), 5579377 (CEC),
5578028 (Attacin), 5565542 (Diptericin), 5579192 (GNBPB1) and
5564993 (Gambicin).
Supporting Information
Table S1 Comparison of the Wolbachia-mediated inhibitory
effect on DENVs as measured by qRT-PCR and plaque assay.
The virus infection was measured in parallel by the two assays in
midguts and whole bodies at 7 days post-infection. Six or five
biological replicates were used in plaque assay or qRT-PCR,
respectively. Data are shown as the median -fold reduction.
Found at: doi:10.1371/journal.ppat.1000833.s001 (0.04 MB
DOC)
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